Melbourne, Victoria, Australia - 13 November 2015
Trajan Scientific and Medical (Trajan) has been announced as one of eleven Victorian businesses receiving a total of $27.4 million to establish or expand high value manufacturing operations under the Next Generation Manufacturing Investment Programme.
Minister for Industry, Innovation and Science Christopher Pyne and Victorian Minister for Industry Lily D’Ambrosio made the announcement at Trajan’s Global Headquarters, saying the investment would help to stimulate economic activity and increase business competitiveness in Victoria.
Mr Pyne said the Australian Government is committed to ensuring a strong and sustainable manufacturing industry in Australia by helping businesses innovate and diversify for the future.
“This investment will help to attract private investment in the sector, building our advanced manufacturing capabilities,” said Mr Pyne.
Ms D’Ambrosio agreed the programme will encourage the growth of advanced manufacturing operations, including in the defence, transportation, pharmaceutical and medical device sectors.
“It will leverage capital investment in precision engineering, robotics and advanced composite materials development, and support businesses to access global supply chains,” said Ms D’Ambrosio.
Chief Executive Officer of Trajan, Stephen Tomisich comments: “Trajan’s grant is investing in Advanced Manufacturing of Precision Scientific and Medical Glass Tubing. This project will expand opportunities to new markets, commercialising products for the medical device sector through utilisation of research technologies.”
Mr Tomisich continues: “Trajan believes the Government’s current discussion on transforming funding for research, and aligning with business opportunities, will ensure a future of research and development translating into economic outcomes for this country. We are enthused and excited by the Government’s refreshed recognition of the importance of innovation within the context of collaboration to the nation’s prosperity.”
Mr Pyne and Ms D’Ambrosio’s presence at Trajan comes exactly one week after Australia’s Prime Minister Malcolm Turnbull visited the company, to hear about its pioneering partnerships with academia and start-ups that are set to become a critical new pillar of the Australian economy.
Mr Tomisich commented at the time of Mr Turnbull’s visit: “Rolling out new models to fund and nurture innovative start-ups, taking those brilliant concepts and ideas nestled in the labs and lecture halls of universities – Trajan identifies these opportunities and in doing so, essentially creates new IP-based, successful and sustainable ideas and enterprises that can deliver long-term economic benefit.”
Photo (L-R): Victorian Minister for Industry Lily D’Ambrosio, Minister for Industry, Innovation and Science Christopher Pyne and Member for Deakin Michael Sukkar.
Premier of Victoria - $75M investment for next generation Victorian manufacturing
Michael Sukkar MP - Trajan Scientific and Medical invests in high value manufacturing
Next Generation Manufacturing Investment Programme
Media Contact Information
Trajan Scientific and Medical
+61 (0) 3 9837 4200
PR Consultancy: LBPR
+61 (0) 429 976 718
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.
Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.